Acumen Pharmaceuticals

BiotechnologySeries ACharlottesville, USacumenpharm.com

Latest round

Series A

Last raised

Apr 2013

Total raised

$21M

Investors

4

About Acumen Pharmaceuticals

Based in Virginia, US, and founded in 1996 by Grant A. Krafft, Acumen Pharmaceuticals, Inc. aka Acumen, operates as a research and drug development company providing treatment solutions for Alzheimer’s disease by helping in reducing soluble oligomers of the amyloid-beta peptide in Alzheimer's disease. The company is a publicly-traded company on NASDAQ by the ticker name of ABOS.4 Million. In April 2013, Acumen Pharmaceuticals, Inc. The company offers ACU193 as an anti-amyloid-beta oligomer (AßO) monoclonal antibody (mAb) and prevents toxic ABOs from binding to dendritic spines thereby perving neural function. ACU193 was a research development between Acumen and Merck.

Who invested in Acumen Pharmaceuticals

4 investors across 2 rounds

See all investors in Acumen Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Apr 25, 2013

    Amount

    $20M

    Investors

    Locked

  2. Series A

    Apr 18, 2013

    Amount

    $0.7M

    Investors

    Locked

Questions about Acumen Pharmaceuticals

Who invested in Acumen Pharmaceuticals?

Acumen Pharmaceuticals has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Acumen Pharmaceuticals raised?

Acumen Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Acumen Pharmaceuticals last raise money?

Acumen Pharmaceuticals's most recent round on record is a Series A, in Apr 2013.

What does Acumen Pharmaceuticals do?

Based in Virginia, US, and founded in 1996 by Grant A.

Where is Acumen Pharmaceuticals headquartered?

Acumen Pharmaceuticals is headquartered in Charlottesville, US.

Which VCs invest in companies like Acumen Pharmaceuticals?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Acumen Pharmaceuticals's stage. Their profiles are linked below.

Raising like Acumen Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.